Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Biological Effects of Radiation02:59

Biological Effects of Radiation

16.2K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
16.2K
Two-Compartment Open Model: IV Bolus Administration01:18

Two-Compartment Open Model: IV Bolus Administration

733
The two-compartment model for intravenous (IV) bolus administration illustrates drug distribution in the body, subdividing it into central and peripheral compartments. This model operates on the concept of two-compartment kinetics. The drug's plasma concentration shows a bi-exponential decline following IV bolus administration, signaling the presence of two disposition processes: distribution and elimination.
The disparity between drug input and the sum of drug transfer rates between...
733
Radioactive Decay and Radiometric Dating02:48

Radioactive Decay and Radiometric Dating

35.3K
Radioactivity is a spontaneous disintegration of an unstable nuclide and is a random process, as all the nuclei in the sample do not decay simultaneously. The number of disintegrations per unit time is called the activity (A), which is directly proportional to the number of nuclei in the sample. The decay constant (λ) is an average probability of decay per nucleus in unit time.
35.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stochastic expansion of radionuclide inhalation dosimetry for consequence management application: uncertainty and sensitivity analysis in the ICRP 130 human respiratory tract model.

Journal of radiological protection : official journal of the Society for Radiological Protection·2026
Same author

Exploratory application of DMD for particle deposition and fluid field in the respiratory tract.

Journal of aerosol science·2026
Same author

Subject-specific modeling framework for particle deposition using computational fluid dynamics.

Journal of aerosol science·2025
Same author

Reconstructing strontium-90 intake in beagles using neural networks: a data-driven assessment of historical inhalation records.

Journal of radiological protection : official journal of the Society for Radiological Protection·2025
Same author

REDCALdep Tool for Particle Deposition Calculations in the Human Respiratory Tract: Applications to Military Exposure Guidelines.

Military medicine·2025
Same author

A Monte Carlo Method for Estimating Secondary Photon Yields from Beta-emitting Radionuclides Concentrated in Environmental Soil.

Health physics·2025

Related Experiment Video

Updated: Sep 26, 2025

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.4K

UPDATED AGE-SPECIFIC EXTERNAL DOSE AND EXPOSURE RATE COEFFICIENTS FOR 131I PATIENT RELEASE.

L Aziz1, S Dewji2

  • 1Department of Nuclear Engineering, Texas A&M University, 3133 TAMU, College Station, TX 77843-3133, USA.

Radiation Protection Dosimetry
|April 19, 2022
PubMed
Summary

New calculations for radiation dose rates from patients treated with iodine-131 (131I) are more accurate than current guidelines. This improves patient release evaluations by considering age-specific factors for external radiation exposure.

More Related Videos

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.1K
Characterization of Recombination Effects in a Liquid Ionization Chamber Used for the Dosimetry of a Radiosurgical Accelerator
07:31

Characterization of Recombination Effects in a Liquid Ionization Chamber Used for the Dosimetry of a Radiosurgical Accelerator

Published on: May 9, 2014

11.9K

Related Experiment Videos

Last Updated: Sep 26, 2025

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.4K
A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.1K
Characterization of Recombination Effects in a Liquid Ionization Chamber Used for the Dosimetry of a Radiosurgical Accelerator
07:31

Characterization of Recombination Effects in a Liquid Ionization Chamber Used for the Dosimetry of a Radiosurgical Accelerator

Published on: May 9, 2014

11.9K

Area of Science:

  • Nuclear Medicine
  • Medical Physics
  • Radiological Protection

Background:

  • Current patient release guidelines for iodine-131 (131I) therapy rely on simplified models.
  • Existing methods, like US Nuclear Regulatory Commission Regulatory Guide (RG) 8.39, do not account for age-specific patient parameters, body shape (morphometry), or time-varying 131I behavior in the body (biodistribution).
  • This can lead to inaccuracies in estimating external radiation exposure to the public from treated patients.

Purpose of the Study:

  • To compute updated effective dose rate and exposure rate coefficients for age-specific individuals.
  • To evaluate external exposure from patients treated with 131I for thyroid dysfunction.
  • To compare these new coefficients with the simplified point source method in RG 8.39.

Main Methods:

  • Utilized Monte Carlo simulations with age-specific phantom models.
  • Integrated modified continuous voiding patient biokinetic models.
  • Approximated age-specific dose and exposure rates as a function of time post-131I administration.

Main Results:

  • Calculated dose rates showed overapproximation compared to RG 8.39.
  • Overapproximation factors were approximately 3 for differentiated thyroid cancer patients (5% uptake) and 2 for hyperthyroid patients (80% uptake) at 8 hours postadministration.
  • Demonstrated significant differences between age-specific models and the simplified RG 8.39 method.

Conclusions:

  • Age-specific morphometry and biokinetic integration are crucial for accurate patient release guidelines.
  • The study provides a new framework for developing more precise guidelines for 131I therapy.
  • This approach is applicable to future radionuclide therapies requiring external exposure assessments.